A new publication involving BPC-157 was released on May 30, 2026. The paper is titled "Unilateral Adrenalectomy, and the Stable Pentadecapeptide BPC 157 as Therapy in Rats - A Cytoprotection Approach." It was published in the journal Pharmaceuticals (Basel, Switzerland).
The publication is listed under PubMed ID 42356491 and can be accessed through PubMed's database. BPC-157 remains classified as an unapproved research compound, meaning it has not been approved by regulatory agencies for human therapeutic use.
This entry reflects only the existence and bibliographic details of the study as recorded. No findings, results, or conclusions from the paper are described here. Readers interested in the specific data, methodology, or outcomes reported in this study should consult the full text directly through the provided source link.
For general background on BPC-157, including its classification and other published research, readers can refer to the compound overview.